Report cover image

Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Aug 22, 2022
Length 93 Pages
SKU # GBDT17412474

Description

Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the HIV Point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Point of Care Testing (POC) is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care.

Scope
  • Extensive coverage of the HIV Point of care (POC) Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of HIV Point of care (POC) Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of HIV Point of care (POC) Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

93 Pages
  • About GlobalData
    • HIV Point of care (POC) Tests Overview
    • HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
    • HIV Point of care (POC) Tests - Pipeline Products by Territory
    • HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
    • HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
    • HIV Point of care (POC) Tests - Ongoing Clinical Trials
    • HIV Point of care (POC) Tests Companies - Pipeline Products by Stage of Development
    • HIV Point of care (POC) Tests - Companies Pipeline Products by Stage of Development
    • Abbott Rapid Diagnostics GmbH Company Overview
    • Access Bio Inc Company Overview
    • Aldatu Biosciences Inc Company Overview
    • Altratech Ltd Company Overview
    • Atomo Diagnostics Ltd Company Overview
    • BBB Technologies Inc Company Overview
    • Beijing Wantai Biological Pharmacy Enterprise Co Ltd Company Overview
    • Binx Health Inc Company Overview
    • Bio-AMD Inc Company Overview
    • Biocartis Group NV Company Overview
    • BioHelix Corp Company Overview
    • Bluejay Diagnostics Inc Company Overview
    • Calypte Biomedical Corporation Company Overview
    • Centre International de Reference Chantal Biya Company Overview
    • Cepheid Inc Company Overview
    • ChipCare Corp Company Overview
    • CrossLife Technologies Inc Company Overview
    • Daktari Diagnostics, Inc. Company Overview
    • Diagnostics For All Inc Company Overview
    • Diagnostics for the Real World (Europe) Ltd Company Overview
    • Endeavor Sciences Inc Company Overview
    • Epinex Diagnostics Inc Company Overview
    • ERBA Molecular Ltd Company Overview
    • Fluxergy LLC Company Overview
    • GAIA Medical Institute LLC Company Overview
    • genedrive plc Company Overview
    • Group K Diagnostics Company Overview
    • Guangzhou Wondfo Biotech Co Ltd Company Overview
    • HeatFlow Technologies Inc Company Overview
    • Identifysensors LLC Company Overview
    • Imperial College London Company Overview
    • Integrated Diagnostics Inc (Inactive) Company Overview
    • Jan Biotech Inc Company Overview
    • Jinvator Bio Med GmbH Company Overview
    • Johns Hopkins University Company Overview
    • Maxim Biomedical Inc Company Overview
    • MedMira Inc Company Overview
    • Micronics Inc Company Overview
    • Molbio Diagnostics Pvt Ltd Company Overview
    • MyMD Pharmaceuticals, Inc Company Overview
    • Nanobiosym Inc Company Overview
    • Newmark Diagnostics LLC Company Overview
    • Northwestern University Company Overview
    • Osel Inc Company Overview
    • Prenetics Ltd Company Overview
    • QuantuMDx Group Ltd Company Overview
    • Quidel Corp Company Overview
    • Radisens Diagnostics Ltd Company Overview
    • Rheonix Inc Company Overview
    • Roche Diagnostics International Ltd Company Overview
    • Sedia Biosciences Corp Company Overview
    • Senzo Inc Company Overview
    • TheoremDx Inc Company Overview
    • Trinity Biotech Plc Company Overview
    • University of Connecticut Company Overview
    • University of Minnesota Company Overview
    • UrSure Inc Company Overview
    • Ustar Biotechnologies (Hangzhou) Ltd. Company Overview
    • Wave 80 Biosciences Inc Company Overview
    • Yaathum Biotech Pvt Ltd Company Overview
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.